Jane Street Group, LLC Pro Phase Labs, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.15 - $9.78 $16,309 - $22,308	-2,281 Reduced 18.23%	10,234 $74,000
Q1 2023 May 15, 2023	BUY	$6.62 - $9.57 $1,655 - $2,392	250 Added 2.04%	12,515 $95,000
Q4 2022 Feb 14, 2023	BUY	$8.78 - $12.47 $107,686 - $152,944	12,265 New	12,265 $118,000
Q3 2019 Nov 14, 2019	SELL	$1.63 - $2.2 $16,661 - $22,488	-10,222 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.1 - $3.07 $21,466 - $31,381	10,222 New	10,222 $22,000

1.71M

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $10.1M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.